BOULDER, Colo., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results on Thursday, February 27, 2014, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in greater detail.
The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.
Anna Sussman 303.625.5022 Breanna Burkart 303.625.5023